Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERT-SEVEREII: Bacterial Expression and Immune Response in Pertussis
NCT05897879Recruiting
- Sponsor
- Institut Pasteur
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Institut Pasteur. Primary endpoints: Expression level of B. pertussis genes at 3 years, Plasma cytokine and chemokine concentrations at 3 years and 1 more. Started Nov 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05897879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897879.